KIN10A Antibody

What is KIN10 and why is it important in plant research?

KIN10 (also called SnRK1α1) is the catalytic subunit of the SNF1-Related Kinase 1 (SnRK1) complex in plants, functionally homologous to the AMP-activated protein kinase (AMPK) in mammals. It serves as a central metabolic sensor that responds to energy depletion and cellular stress . KIN10 plays crucial roles in regulating autophagy, lipid metabolism, and stress responses, making it a focal point for understanding plant metabolic regulation . Studies have demonstrated that KIN10 influences multiple signaling pathways by phosphorylating downstream targets, including transcription factors and metabolic enzymes, thus coordinating plant growth and development in response to changing environmental conditions . Antibodies against KIN10 enable researchers to detect, quantify, and study the localization and post-translational modifications of this important regulatory protein.

How does KIN10A antibody differ from other KIN10 antibodies?

KIN10A antibody specifically targets unique epitopes of the KIN10 protein that distinguish it from closely related kinases. While the search results don't explicitly detail the differences between KIN10A and other KIN10 antibodies, typical distinctions would involve epitope recognition, species reactivity, and application suitability. KIN10A antibody is likely raised against specific domains of the KIN10 protein, such as the protein kinase domain (CD), the ubiquitin-associated domain (UBA), or the kinase associated domain 1 (KA1) . These domain-specific antibodies allow researchers to investigate different aspects of KIN10 function, potentially differentiating between active and inactive states or detecting specific post-translational modifications. When selecting a KIN10 antibody, researchers should consider which specific domains or modifications they need to detect for their particular experimental questions.

What applications are suitable for KIN10A antibody in plant science?

KIN10A antibody can be employed in multiple research applications studying plant energy metabolism and stress responses. Primary applications include:

• Western blotting: For detecting and quantifying KIN10 protein levels, as demonstrated in studies examining YFP-tagged ATG1a protein levels in plants with KIN10 overexpression . The antibody can detect both native and phosphorylated forms of KIN10, allowing researchers to assess its activation state.

• Immunoprecipitation: For isolating KIN10 protein complexes to study protein-protein interactions, as might be necessary when investigating KIN10's relationship with autophagy-related proteins like ATG1 .

• Immunohistochemistry/Immunofluorescence: For examining the subcellular localization of KIN10 in different plant tissues and under various stress conditions, though specific protocols for these applications weren't detailed in the search results.

• Chromatin immunoprecipitation (ChIP): For studying KIN10's interaction with chromatin when investigating its role in transcriptional regulation, particularly in contexts where KIN10 influences gene expression related to autophagy or metabolism .

Researchers should optimize antibody concentrations for each application based on the specific experimental conditions and sample types being analyzed.

How should researchers optimize Western blot protocols for KIN10A antibody?

Optimizing Western blot protocols for KIN10A antibody requires careful attention to several key parameters. Based on the experimental approaches described in the literature, researchers should consider the following methodology:

Sample preparation: Total protein should be extracted in ice-cold protein extraction buffer supplemented with protease inhibitors (like phenylmethylsulfonyl fluoride and cocktail inhibitors) and phosphatase inhibitors (such as PhosSTOP) if phosphorylated forms are of interest . For plant tissues, homogenization should be performed on ice, followed by 30-minute incubation and centrifugation at approximately 11,000 g to obtain clear lysates .

Gel electrophoresis: SDS-PAGE with 8-12% polyacrylamide gels is typically suitable for resolving KIN10 (~58-60 kDa), though higher percentage gels may be needed to clearly separate phosphorylated from non-phosphorylated forms. Loading 20-50 μg of total protein per lane is generally appropriate, though this may need adjustment based on expression levels in specific tissues or experimental conditions.

Transfer and blocking: Electrophoretic transfer to PVDF or nitrocellulose membranes (like Hybond-C) followed by blocking with 5% non-fat dry milk or BSA in TBST for 1-2 hours at room temperature is recommended . For detecting phosphorylated forms, BSA is preferable as milk contains phosphoproteins that can increase background.

Antibody incubation: Primary antibody dilutions typically range from 1:1000 to 1:5000, incubated overnight at 4°C, though optimal dilution should be determined empirically. After washing, appropriate HRP-conjugated secondary antibodies should be applied at 1:5000 to 1:10000 dilutions for 1-2 hours at room temperature.

Detection: Enhanced chemiluminescence (ECL) detection systems provide sufficient sensitivity for most applications. For lower abundance forms or subtle changes in phosphorylation state, more sensitive detection systems may be necessary.

Researchers should include appropriate positive controls (such as recombinant KIN10 or overexpression lines) and negative controls (such as kin10 knockdown lines) to validate antibody specificity .

What controls are essential when performing immunoprecipitation with KIN10A antibody?

When performing immunoprecipitation (IP) with KIN10A antibody to study protein-protein interactions or post-translational modifications, several essential controls must be implemented to ensure reliable results:

• Input control: 5-10% of the total lysate used for IP should be set aside before antibody addition to confirm the presence of target proteins in the starting material.

• Negative control antibody: A non-specific antibody of the same isotype (typically normal IgG from the same species as the KIN10A antibody) should be used in parallel IP reactions to identify non-specific binding.

• Knockout/knockdown control: Whenever possible, perform parallel IP using tissues from KIN10 knockout or RNAi knockdown plants to confirm antibody specificity . This control is particularly important when studying novel interactions.

• Reciprocal IP: To confirm protein-protein interactions, perform reverse IP using antibodies against the putative interacting partner. For example, if studying KIN10 interaction with ATG1, perform IP with both KIN10A antibody and ATG1 antibody.

• Phosphatase treatment control: When studying phosphorylation states, include samples treated with λ phosphatase to confirm that higher molecular weight bands are indeed due to phosphorylation rather than other modifications . Include phosphatase inhibitor controls (like PhosSTOP) to prevent dephosphorylation during extraction.

• Denaturing vs. non-denaturing conditions: Consider performing IP under both conditions to distinguish between direct and indirect interactions in protein complexes.

For interactions between KIN10 and autophagy-related proteins, yeast two-hybrid assays have proven useful as complementary approaches to verify results from IP experiments .

How can researchers quantify KIN10 phosphorylation status using antibodies?

Quantifying KIN10 phosphorylation status is crucial for understanding its activation in response to energy status and stress conditions. Several methodological approaches are available:

Phospho-specific antibodies: When available, antibodies that specifically recognize phosphorylated residues on KIN10 provide the most direct approach. These should be used alongside total KIN10 antibodies to calculate the phosphorylation ratio.

Mobility shift assays: KIN10 phosphorylation typically causes a mobility shift on SDS-PAGE that can be detected with total KIN10 antibodies. This approach involves quantifying the ratio of shifted (phosphorylated) to non-shifted (non-phosphorylated) bands . For enhanced resolution of phosphorylated species, Phos-tag acrylamide gels can be utilized.

Phosphatase treatment comparison: Treating protein extracts with λ phosphatase before Western blotting can confirm that higher molecular weight bands represent phosphorylated forms . The difference in band intensity between phosphatase-treated and untreated samples indicates phosphorylation levels.

Mass spectrometry validation: For comprehensive analysis, immunoprecipitated KIN10 can be analyzed by mass spectrometry to identify specific phosphorylation sites and their relative abundance.

For quantification, researchers should use appropriate image analysis software (like ImageJ) to measure band intensities, normalizing phosphorylated KIN10 to total KIN10 levels. When examining KIN10's role in regulating target proteins such as ATG1, similar approaches can be applied to quantify downstream phosphorylation events . Carefully controlled experimental conditions are essential, as phosphorylation status can change rapidly during sample preparation.

How can researchers address non-specific binding issues with KIN10A antibody?

Non-specific binding can significantly compromise experimental results when working with KIN10A antibody. To address these technical challenges effectively:

Antibody validation: Before proceeding with experiments, validate antibody specificity using knockout/knockdown lines (such as KIN10-RNAi lines) as negative controls . A specific antibody should show significantly reduced or absent signal in tissues with reduced KIN10 expression.

Blocking optimization: Test different blocking agents (BSA, non-fat dry milk, commercial blocking buffers) at various concentrations (3-5%) to minimize background. For plant samples with high carbohydrate content, adding 0.1-0.5% Tween-20 to blocking and washing buffers can help reduce non-specific binding.

Cross-reactivity testing: Evaluate potential cross-reactivity with related kinases, particularly KIN11, which is functionally redundant with KIN10 in Arabidopsis . When possible, include recombinant KIN10 and KIN11 proteins as controls to assess specificity.

Antibody titration: Determine the optimal antibody concentration that maximizes specific signal while minimizing background. This typically involves testing serial dilutions (1:500 to 1:5000) under consistent experimental conditions.

Pre-absorption: If cross-reactivity persists, consider pre-absorbing the antibody with recombinant proteins of related kinases to remove antibodies that recognize shared epitopes.

For particularly challenging applications, epitope-tagged KIN10 constructs (such as YFP-KIN10) expressed in transgenic plants can be used with well-characterized tag antibodies (anti-GFP/YFP) as an alternative approach, similar to the YFP-ATG1a system described in the literature .

What factors affect KIN10 protein detection in different plant tissues?

Detecting KIN10 protein across different plant tissues presents several challenges influenced by biological and technical factors:

Expression level variations: KIN10 expression naturally varies across tissue types, developmental stages, and in response to environmental conditions. Root and developing seeds often show higher expression than mature leaves under non-stress conditions. Researchers should adjust protein loading based on tissue-specific expression patterns.

Protein extraction efficiency: Different plant tissues require optimized extraction protocols due to varying compositions of interfering compounds. Woody tissues, seeds, and tissues rich in phenolics or secondary metabolites may require specialized extraction buffers containing PVPP (polyvinylpolypyrrolidone), higher concentrations of reducing agents, or specific detergents to improve protein recovery.

Post-translational modifications: The phosphorylation status of KIN10 varies across tissues and in response to stresses like carbon starvation . This affects antibody recognition and detection sensitivity. Using phosphatase treatments as controls can help distinguish these effects.

Protein stability and turnover: KIN10 protein stability varies conditionally. For instance, interaction with GEMINIVIRUS REP INTERACTING KINASE1 results in KIN10 phosphorylation and subsequent degradation . Adding proteasome inhibitors (like MG132) during extraction may be necessary for tissues with high turnover rates.

Interfering compounds: Plant tissues contain varying levels of compounds that can interfere with antibody binding or cause background issues. These include pigments, phenolics, lipids, and carbohydrates. TCA/acetone precipitation or phenol-based extraction methods may improve protein purity for problematic tissues.

When comparing KIN10 levels across tissues, researchers should normalize to appropriate housekeeping proteins that show stable expression in the specific tissues being compared. For absolute quantification, including known amounts of recombinant KIN10 protein as standards is recommended.

How should researchers interpret contradictory results between antibody-based methods and gene expression analysis?

Discrepancies between KIN10 protein levels (detected by antibodies) and gene expression (measured by qRT-PCR or RNA-seq) are common and reflect important biological phenomena rather than technical failures. Researchers should systematically approach these contradictions:

Post-transcriptional regulation: KIN10 may be subject to microRNA-mediated regulation or RNA processing that affects translation efficiency without changing transcript abundance. Comparing total transcript levels with protein levels can reveal such regulation mechanisms.

Protein stability and turnover: KIN10 protein undergoes regulated degradation, particularly in response to energy status changes . While transcript levels may remain constant, protein levels can fluctuate due to proteasomal degradation. Performing cycloheximide chase experiments can help determine protein half-life across conditions.

Translation efficiency: Stress conditions can globally suppress translation while maintaining transcript levels. Polysome profiling of KIN10 mRNA can determine if translation efficiency changes under experimental conditions.

Post-translational modifications: Modifications like phosphorylation can affect antibody recognition without changing protein abundance. Using multiple antibodies targeting different epitopes or combining with mass spectrometry analysis can resolve these issues.

Sensitivity differences: qRT-PCR typically has greater sensitivity than Western blotting, potentially detecting expression in samples where protein levels fall below antibody detection limits. Establishing the linear detection range for both methods is essential for proper interpretation.

A comprehensive approach combining transcript analysis, protein detection, polysome profiling, and protein degradation assays provides the most complete understanding of KIN10 regulation. The literature shows examples where total transcript levels of ATG1a were enhanced in YFP-ATG1a KIN10-OE lines while YFP-ATG1a protein levels changed differently, highlighting the importance of examining both transcriptional and post-transcriptional regulation .

How can KIN10A antibody be used to study protein-protein interactions in the SnRK1 signaling pathway?

KIN10A antibody offers powerful approaches for dissecting protein-protein interactions within the SnRK1 signaling pathway, providing insights into energy sensing mechanisms in plants. Methodological approaches include:

Co-immunoprecipitation (Co-IP): KIN10A antibody can be used to pull down KIN10 along with its interacting partners from plant extracts. This approach has revealed interactions between KIN10 and autophagy-related proteins . For reliable Co-IP results, researchers should use mild lysis conditions to preserve protein complexes and include appropriate controls as detailed in section 2.2.

Proximity-dependent biotin identification (BioID): By fusing a promiscuous biotin ligase to KIN10 and using streptavidin pulldown followed by detection with KIN10A antibody, researchers can identify proteins that transiently interact with KIN10 in living cells. This approach complements traditional Co-IP by capturing weaker or more dynamic interactions.

Bimolecular fluorescence complementation (BiFC): Though not directly using antibodies, this technique can validate KIN10 interactions identified through antibody-based methods. Split fluorescent protein fragments are fused to KIN10 and putative partners, reconstituting fluorescence when proteins interact.

Förster resonance energy transfer (FRET): Antibodies labeled with fluorophores can be used in acceptor photobleaching FRET to study proximity between KIN10 and interacting partners in fixed cells or tissues.

Yeast two-hybrid (Y2H) validation: The literature demonstrates successful use of Y2H assays to validate KIN10 interactions with autophagy-related proteins (ATG1a, ATG1b, ATG1c, ATG6, ATG8e, ATG9, PI3K, ATG13a, and ATG13b) . These interactions can be further confirmed using the antibody-based methods above.

The current research highlights that KIN10 interacts with specific domains of autophagy proteins. For example, interactions between KIN10's protein kinase domain (CD), ubiquitin-associated domain (UBA), and kinase associated domain 1 (KA1) with ATG1a and ATG13a have been demonstrated . These findings provide a foundation for more detailed studies of how these interactions regulate autophagy induction under energy stress conditions.

What methodologies combine KIN10A antibody with phosphoproteomics to identify downstream targets?

Integrating KIN10A antibody-based techniques with phosphoproteomics offers powerful approaches to comprehensively identify KIN10 substrates and signaling networks. Recommended methodological frameworks include:

Substrate identification workflow:

• Immunoprecipitate KIN10 using KIN10A antibody from plants under control and stress conditions to obtain active kinase.

• Perform in vitro kinase assays using the immunoprecipitated KIN10 and protein extracts or recombinant candidate substrates.

• Analyze phosphorylated proteins by mass spectrometry, focusing on phosphosites matching the KIN10 consensus motif.

• Validate candidates using phospho-specific antibodies against identified sites.

Comparative phosphoproteomics:

• Compare phosphoproteomic profiles between wild-type, KIN10 overexpression, and KIN10-RNAi lines under normal and stress conditions .

• Identify phosphopeptides differentially abundant between genotypes that match the KIN10 consensus motif.

• Validate using recombinant proteins and in vitro kinase assays.

Chemical genetics approach:

• Generate transgenic plants expressing an analog-sensitive KIN10 mutant that can utilize bulky ATP analogs.

• Use KIN10A antibody to confirm expression and activity of the engineered kinase.

• Apply the ATP analog in vivo or in extracts to specifically label KIN10 substrates.

• Identify labeled proteins by mass spectrometry.

Phosphorylation dynamics:

• Perform time-course experiments during stress responses in wild-type and KIN10 transgenic lines.

• Use KIN10A antibody to monitor KIN10 activation kinetics via Western blotting.

• Correlate KIN10 activation with downstream substrate phosphorylation using phospho-specific antibodies.

The research demonstrates that KIN10 influences ATG1 phosphorylation status, with enhanced phosphorylation observed in YFP-ATG1a KIN10-OE lines compared to control lines, particularly under carbon starvation conditions . This methodological approach could be extended to identify other KIN10 substrates involved in autophagy regulation and metabolic control.

How can researchers use KIN10A antibody to investigate cross-talk between SnRK1 and TOR signaling pathways?

The cross-talk between SnRK1 (represented by KIN10) and Target of Rapamycin (TOR) signaling pathways represents a crucial regulatory node in plant energy homeostasis. KIN10A antibody enables sophisticated experimental approaches to dissect this interaction:

Reciprocal regulation analysis:

• Use KIN10A antibody to monitor KIN10 phosphorylation and stability in plants treated with TOR inhibitors (like rapamycin with FKBP12 or AZD8055).

• Conversely, examine TOR phosphorylation and activity (using phospho-specific TOR antibodies) in KIN10 overexpression and RNAi lines .

• Quantify changes in both pathways' activation states under different energy and nutrient conditions.

Protein complex dynamics:

• Perform sequential immunoprecipitation (first with KIN10A antibody, then with TOR pathway component antibodies) to identify protein complexes containing components of both pathways.

• Use proximity ligation assays with KIN10A antibody and antibodies against TOR pathway components to visualize interactions in situ.

• Investigate how complex formation changes under different nutrient and energy conditions.

Substrate competition studies:

• Identify shared substrates between KIN10 and TOR using the phosphoproteomic approaches described in section 4.2.

• Examine how phosphorylation of these substrates changes in plants with altered KIN10 or TOR activity.

• Use in vitro competition assays with immunoprecipitated kinases to determine substrate preferences.

Autophagy regulation investigation:

• Monitor autophagosome formation using GFP-ATG8e fluorescence microscopy in plants with altered KIN10 activity .

• Compare results with TOR inhibition experiments to determine if KIN10 and TOR regulate autophagy through shared or distinct mechanisms.

• Use KIN10A antibody to examine KIN10's association with autophagy-related proteins under conditions where TOR is inhibited.

The literature suggests that ULK1 (mammalian ortholog of yeast ATG1) is phosphorylated by both AMPK to activate autophagy and TOR to repress autophagy . The plant counterpart, ATG1, shows enhanced phosphorylation in KIN10 overexpression lines, suggesting a similar regulatory mechanism may exist in plants . Understanding whether KIN10 promotes autophagy by directly phosphorylating ATG1 or by suppressing TOR activity (which otherwise inhibits ATG1) represents an important area for investigation using these methodological approaches.

How might advanced microscopy techniques enhance KIN10A antibody applications?

Advanced microscopy techniques offer exciting opportunities to expand KIN10A antibody applications beyond traditional biochemical approaches, providing spatial and temporal insights into KIN10 function:

Super-resolution microscopy:

• Techniques like Structured Illumination Microscopy (SIM), Stimulated Emission Depletion (STED) microscopy, and Photoactivated Localization Microscopy (PALM) can reveal KIN10 subcellular localization with nanometer precision.

• Combined with immunofluorescence using KIN10A antibodies, these techniques can visualize KIN10 association with cellular structures like autophagosomes, particularly during stress responses .

• Dual-color super-resolution microscopy with antibodies against KIN10 and interaction partners can confirm co-localization at sub-diffraction resolution.

Live-cell imaging methodologies:

• Although direct antibody application requires fixed cells, genetically encoded biosensors based on KIN10 substrate phosphorylation combined with KIN10A antibody validation can enable real-time monitoring of KIN10 activity in living cells.

• FRET-based reporters designed around known KIN10 substrates provide dynamic readouts of KIN10 activity, with antibody-based techniques serving for calibration and validation.

Correlative light and electron microscopy (CLEM):

• KIN10A antibodies conjugated to both fluorescent dyes and electron-dense particles allow precise localization from tissue to nanoscale levels.

• This approach can relate KIN10 localization to ultrastructural features like forming autophagosomes or stress granules during energy deprivation.

Single-molecule imaging:

• Using highly sensitive detection methods, single-molecule imaging with fluorescently labeled KIN10A antibody fragments can track individual KIN10 molecules.

• This approach could reveal heterogeneity in KIN10 behavior and rare interaction events not detectable in bulk assays.

The literature demonstrates that overexpression of KIN10 enhances autophagosome formation, as visualized using GFP-ATG8e fluorescence microscopy . Combining these observed phenotypes with advanced microscopy techniques using KIN10A antibodies would provide unprecedented insights into how KIN10 spatially and temporally regulates the autophagy machinery at the molecular level.

What methodological approaches can detect tissue-specific activation of KIN10 during plant development?

Understanding tissue-specific KIN10 activation patterns during plant development requires sophisticated methodologies that combine KIN10A antibody applications with spatial resolution techniques:

Tissue-specific immunohistochemistry:

• Optimize fixation and embedding protocols for different plant tissues to preserve KIN10 phosphorylation status.

• Use phospho-specific KIN10A antibodies alongside total KIN10A antibodies on tissue sections to map activation patterns.

• Apply multiplexed immunofluorescence to simultaneously detect KIN10 activation and tissue-specific markers.

Laser capture microdissection combined with immunoblotting:

• Isolate specific cell types or tissue regions using laser capture microdissection.

• Extract proteins and perform Western blotting with KIN10A antibody to determine KIN10 levels and phosphorylation status in different cell populations.

• Compare activation patterns across developmental stages and tissue types.

Tissue-specific pull-down assays:

• Generate plants expressing epitope-tagged KIN10 under tissue-specific promoters.

• Perform immunoprecipitation with epitope antibodies from different tissues.

• Assess KIN10 activation state and interacting partners across tissues using KIN10A and phospho-specific antibodies.

Epitope-tagged reporter lines:

• Create transgenic lines expressing KIN10-YFP fusion under native or tissue-specific promoters.

• Validate reporter line fidelity using KIN10A antibodies.

• Monitor KIN10 localization, abundance, and potential degradation in different tissues during development and stress responses.

The research shows that KIN10 plays distinct roles in different physiological contexts, delaying natural and nitrogen starvation-induced senescence while promoting autophagy under stress conditions . These observations suggest tissue-specific activation patterns that could be further explored using the methodological approaches described above. The finding that KIN10 affects ATG1 phosphorylation status differentially under carbon starvation conditions indicates that KIN10 activation is stress-responsive and likely varies across tissues with different metabolic demands .

How can computational approaches be integrated with KIN10A antibody data to model kinase networks?

Integrating computational modeling with experimental data generated using KIN10A antibodies can provide systems-level insights into kinase networks and their dynamic regulation. Methodological approaches include:

Kinetic modeling of signaling networks:

• Use quantitative Western blot data with KIN10A antibodies to measure KIN10 activation dynamics under various conditions.

• Develop ordinary differential equation (ODE) models incorporating KIN10 phosphorylation, substrate interactions, and downstream effects.

• Parameterize models using experimental data and validate predictions with new experiments.

• Simulate network behavior under untested conditions to guide future experiments.

Bayesian network inference:

• Generate time-course data of KIN10 activation and downstream substrate phosphorylation using KIN10A and phospho-specific antibodies.

• Apply Bayesian network inference algorithms to predict causal relationships within the signaling network.

• Test inferred relationships experimentally to refine network models.

Machine learning classification:

• Develop image analysis algorithms to automatically quantify immunofluorescence patterns from KIN10A antibody staining.

• Train classification models to distinguish different activation states or localization patterns.

• Apply across large datasets to identify subtle phenotypes not apparent through manual analysis.

Multi-omics data integration:

• Combine KIN10A antibody data with transcriptomics, metabolomics, and phenomics datasets.

• Use dimensionality reduction and clustering algorithms to identify patterns correlating KIN10 activity with global cellular states.

• Generate hypotheses about novel KIN10 functions or regulatory relationships.

The research shows that KIN10 influences multiple downstream processes, including autophagy regulation, stress responses, and lipid metabolism . Computational modeling could help integrate these diverse functions into a coherent understanding of how KIN10 orchestrates cellular responses to energy status. For example, the observed relationship between KIN10 overexpression and enhanced formation of autophagosomes could be incorporated into models predicting how perturbations in energy sensing affect autophagy flux under different stress conditions .